{"mainPropery":{"diseaseId":5862,"diseaseName":"Ataxia telangiectasia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5862/ataxia-telangiectasia","synonyms":["AT","Louis-Bar syndrome","Cerebello-oculocutaneous telangiectasia","Immunodeficiency with ataxia telangiectasia"],"synonyms-with-source":[{"name":"AT"},{"name":"Louis-Bar syndrome"},{"name":"Cerebello-oculocutaneous telangiectasia"},{"name":"Immunodeficiency with ataxia telangiectasia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"208900"},{"identifierType":"ORPHANET","identifierId":"100"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":10,"diseaseTypeName":"Female Reproductive Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":44,"resourceName":"National Ataxia Foundation","abbreviation":"","address1":"600 Highway 169 South","address2":"Suite 1725","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55426","country":"United States","phone":"+1-763-553-0020","tty":"","tollFree":"","fax":"+1-763-553-0167","email":"naf@ataxia.org","url":"https://ataxia.org/","freeText":""},{"resourceID":46,"resourceName":"euro-ATAXIA (European Federation of Hereditary Ataxias)","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.euroataxia.org/","freeText":""},{"resourceID":187,"resourceName":"A-T Children's Project","abbreviation":"","address1":"5300 W. Hillsboro Blvd","address2":"Suite 105","address3":"","address4":"","address5":"","city":"Coconut Creek","state":"FL","zip":"33073","country":"United States","phone":"800-5-HELP-AT (800-543-5728); 954-481-6611 ","tty":"","tollFree":"","fax":"954-725-1153 ","email":"info@atcp.org","url":"http://www.atcp.org","freeText":""},{"resourceID":3751,"resourceName":"Global A-T Family Data Platform"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/208900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=208900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Ataxia telangiectasia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Ataxia+telangiectasia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Ataxia telangiectasia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=ataxiatelangiectasia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Ataxia telangiectasia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0004135[DISCUI]&test_type=Clinical&display_string=Ataxia-telangiectasia%20syndrome&condition=C0004135' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/406/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001394.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/health_and_medical/disorders/a-t.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1113394-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022360' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=100' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ataxia-telangiectas' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/factsheet/risk/ataxia' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2076,"resourceId":2843,"resourceName":"Coordination of Rare Diseases at Sanford (CoRDS)","descriptionText":"<a href='http://www.sanfordresearch.org/cords/patientsfamilies/' target='_blank'>Coordination of Rare Diseases at Sanford (CoRDS)</a> hosts a specific registry for patients with ataxia in partnership with the National Ataxia Foundation. The goal of the CoRDS registry is to connect as many patients and researchers as possible to help advance treatments and cures for rare diseases. The CoRDS registry is free for patients to enroll and for researchers to access.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:208900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2444,"resourceId":3751,"resourceName":"Global A-T Family Data Platform","descriptionText":"<span style=\"font-family: Roboto, Verdana, Geneva, Tahoma, sans-serif; color: #333333;\">The goal of the <a href='https://atfamilies.org/' target='_blank'>Global A-T Family Data Platform</a> is to connect patient health, genomic, and potentially other types of data  to scientists and researchers who are interested in advancing the understanding, diagnosis and treatment of ataxia telangiectasia.<br />\r\n</span>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Ataxia telangiectasia. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Ataxia telangiectasia:<br />\r\n<a href='http://esid.org/Working-Parties/Registry' target='_blank'>European Society for Immunodeficiencies (ESID) Registry</a><br /><a href='https://usidnet.org/about-the-registry/patient-participation/' target='_blank'>United States Immunodeficiency Network (USIDENT) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":4557,"questionText":"What is ataxia telangiectasia?","answerText":"<strong>Ataxia telangiectasia (A-T)</strong> is rare condition that affects the nervous system, the immune system, and many other parts of the body. Signs and symptoms of the condition usually begin in early childhood, often before age 5. The condition is&nbsp;typically characterized by cerebellar ataxia (uncoordinated muscle movements), <a href=\"http://www.aapos.org/terms/conditions/138\" target=\"_blank\">oculomotor apraxia</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003284.htm\" target=\"_blank\">telangiectasias</a>, choreoathetosis (uncontrollable movements of the limbs), a weakened immune system with frequent infections, and an increased risk of cancers such as <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/001299.htm\" target=\"_blank\">leukemia</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/lymphoma.html\" target=\"_blank\">lymphoma</a>.[3517][11154] A-T is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>)  in the <em><a href=\"http://ghr.nlm.nih.gov/gene/ATM\" target=\"_blank\">ATM</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[3519] Treatment is supportive and based on the signs and symptoms present in each person.[11154]","dateModified":"2016-04-05T00:00:00"},"basicQuestions":[{"questionId":4558,"questionText":"What are the signs and symptoms of ataxia telangiectasia?","answerText":"Ataxia-telangiectasia affects the nervous system, immune system, and other body systems. This disorder is characterized by progressive difficulty with coordinating movements (ataxia) beginning in early childhood, usually before age 5. Affected children typically develop difficulty walking, problems with balance and hand coordination, involuntary jerking movements (chorea), muscle twitches (myoclonus), and disturbances in nerve function (neuropathy). The movement problems typically cause people to require wheelchair assistance by adolescence. People with this disorder also have slurred speech and trouble moving their eyes to look side-to-side (oculomotor apraxia). Small clusters of enlarged blood vessels called telangiectases, which occur in the eyes and on the surface of the skin, are also characteristic of this condition.[3519]<br />\r\n<br />\r\nAffected individuals tend to have high amounts of a protein called alpha-fetoprotein (AFP) in their blood. The level of this protein is usually increased in the bloodstream of pregnant women. The effect of abnormally high levels of AFP in people with ataxia-telangiectasia is unknown.[3519]<br />\r\n<br />\r\nPeople with ataxia-telangiectasia often have a weakened immune system, and many develop chronic lung infections. They are also at an increased risk of developing cancer, particularly leukemia and lymphoma. Affected individuals are very sensitive to the effects of radiation exposure, including medical x-rays. Although people with ataxia-telangiectasia usually live into adulthood, their life expectancy is reduced.[3519]","dateModified":"2016-04-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3519,"authors":"","articleTitle":"Ataxia-telangiectasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/ataxia-telangiectasia","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12859,"relatedDiseaseName":"Autosomal Recessive Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":5107,"relatedDiseaseName":"T cell immunodeficiency primary","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":30790,"abbreviatedInquiry":"How&nbsp;might&nbsp;ataxia telangiectasia&nbsp;affect a person's ability to move and speak?","caseQuestions":[{"questionId":4557,"questionText":"What is ataxia telangiectasia?","answerText":"<strong>Ataxia telangiectasia (A-T)</strong> is rare condition that affects the nervous system, the immune system, and many other parts of the body. Signs and symptoms of the condition usually begin in early childhood, often before age 5. The condition is&nbsp;typically characterized by cerebellar ataxia (uncoordinated muscle movements), <a href=\"http://www.aapos.org/terms/conditions/138\" target=\"_blank\">oculomotor apraxia</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003284.htm\" target=\"_blank\">telangiectasias</a>, choreoathetosis (uncontrollable movements of the limbs), a weakened immune system with frequent infections, and an increased risk of cancers such as <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/001299.htm\" target=\"_blank\">leukemia</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/lymphoma.html\" target=\"_blank\">lymphoma</a>.[3517][11154] A-T is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>)  in the <em><a href=\"http://ghr.nlm.nih.gov/gene/ATM\" target=\"_blank\">ATM</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[3519] Treatment is supportive and based on the signs and symptoms present in each person.[11154]","dateModified":"2016-04-05T00:00:00","references":[{"referenceId":3517,"authors":"","articleTitle":"NINDS Ataxia Telangiectasia Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"July, 2015","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/a_t/a-t.htm","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3519,"authors":"","articleTitle":"Ataxia-telangiectasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/ataxia-telangiectasia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11154,"authors":"Richard Gatti, MD","articleTitle":"Ataxia-Telangiectasia","bookWebsiteJournalTitle":"GeneReviews","date":"March 2010","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK26468","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4558,"questionText":"What are the signs and symptoms of ataxia telangiectasia?","answerText":"Ataxia-telangiectasia affects the nervous system, immune system, and other body systems. This disorder is characterized by progressive difficulty with coordinating movements (ataxia) beginning in early childhood, usually before age 5. Affected children typically develop difficulty walking, problems with balance and hand coordination, involuntary jerking movements (chorea), muscle twitches (myoclonus), and disturbances in nerve function (neuropathy). The movement problems typically cause people to require wheelchair assistance by adolescence. People with this disorder also have slurred speech and trouble moving their eyes to look side-to-side (oculomotor apraxia). Small clusters of enlarged blood vessels called telangiectases, which occur in the eyes and on the surface of the skin, are also characteristic of this condition.[3519]<br />\r\n<br />\r\nAffected individuals tend to have high amounts of a protein called alpha-fetoprotein (AFP) in their blood. The level of this protein is usually increased in the bloodstream of pregnant women. The effect of abnormally high levels of AFP in people with ataxia-telangiectasia is unknown.[3519]<br />\r\n<br />\r\nPeople with ataxia-telangiectasia often have a weakened immune system, and many develop chronic lung infections. They are also at an increased risk of developing cancer, particularly leukemia and lymphoma. Affected individuals are very sensitive to the effects of radiation exposure, including medical x-rays. Although people with ataxia-telangiectasia usually live into adulthood, their life expectancy is reduced.[3519]","dateModified":"2016-04-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3519,"authors":"","articleTitle":"Ataxia-telangiectasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/ataxia-telangiectasia","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14521,"phenoTypeName":"Abnormality of chromosome stability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11065,"phenoTypeName":"Aplasia/Hypoplasia of the thymus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8205,"phenoTypeName":"Cellular immunodeficiency","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3592,"phenoTypeName":"Decreased circulating antibody level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6028,"phenoTypeName":"Delayed puberty","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15526,"phenoTypeName":"Lymphopenia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6927,"phenoTypeName":"Mucosal telangiectasiae","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9740,"phenoTypeName":"Polycystic ovaries","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8085,"phenoTypeName":"Premature graying of hair","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6924,"phenoTypeName":"Telangiectasia of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15056,"phenoTypeName":"Hypopigmentation of hair","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13290,"phenoTypeName":"Neoplasm","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13,"phenoTypeName":"Abnormal testis morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14465,"phenoTypeName":"Aplasia/Hypoplasia of the skin","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":925,"phenoTypeName":"Multiple cafe-au-lait spots","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3505,"phenoTypeName":"Type II diabetes mellitus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4755,"phenoTypeName":"Abnormal hair morphology","percentRanges":"-"},{"phenoTypeId":6201,"phenoTypeName":"Abnormal spermatogenesis","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13740,"phenoTypeName":"Bronchiectasis","percentRanges":"-"},{"phenoTypeId":10286,"phenoTypeName":"Cafe-au-lait spot","percentRanges":"-"},{"phenoTypeId":8726,"phenoTypeName":"Choreoathetosis","percentRanges":"-"},{"phenoTypeId":5628,"phenoTypeName":"Conjunctival telangiectasia","percentRanges":"-"},{"phenoTypeId":10672,"phenoTypeName":"Decreased circulating IgA level","percentRanges":"-"},{"phenoTypeId":15637,"phenoTypeName":"Decreased circulating IgG2 level","percentRanges":"-"},{"phenoTypeId":8219,"phenoTypeName":"Decreased proportion of CD4-positive helper T cells","percentRanges":"-"},{"phenoTypeId":8194,"phenoTypeName":"Defective B cell differentiation","percentRanges":"-"},{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","percentRanges":"-"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","percentRanges":"-"},{"phenoTypeId":2518,"phenoTypeName":"Elevated alpha-fetoprotein","percentRanges":"-"},{"phenoTypeId":9727,"phenoTypeName":"Female hypogonadism","percentRanges":"-"},{"phenoTypeId":13052,"phenoTypeName":"Glucose intolerance","percentRanges":"-"},{"phenoTypeId":4891,"phenoTypeName":"Hodgkin lymphoma","percentRanges":"-"},{"phenoTypeId":14157,"phenoTypeName":"Hypoplasia of the thymus","percentRanges":"-"},{"phenoTypeId":15545,"phenoTypeName":"Leukemia","percentRanges":"-"},{"phenoTypeId":13815,"phenoTypeName":"Lymphoma","percentRanges":"-"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","percentRanges":"-"},{"phenoTypeId":15306,"phenoTypeName":"Non-Hodgkin lymphoma","percentRanges":"-"},{"phenoTypeId":7927,"phenoTypeName":"Recurrent bronchitis","percentRanges":"-"},{"phenoTypeId":9404,"phenoTypeName":"Reduced tendon reflexes","percentRanges":"-"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Ataxia_telangiectasia"}